All stocks · United States
Regeneron Pharmaceuticals (REGN): stock price and analysis
Price as of 2026-11-06, updated daily · simple page
The short answer
Current trend (a fact, not a forecast)Trending up
The price is above its 200-session average and above its 50-session average. Over 3 months: +12.0%. The radar's AI does not give a call on this stock yet: nobody can reliably say whether it will rise next month.
How much does it usually move?±15% in a monthOver two years, 8 months in 10 between -11% and +13%
Key figures
| Last price | $904.35 (2026-11-06) |
|---|---|
| Day change | +0.16% |
| 1-year high | $973.36 |
| 1-year low | $599.96 |
| Max drawdown (1 year) | -25.9% |
| Volatility (last 20 sessions) | 54% a year |
| Best / worst month (2 years) | +32.3% / -23.1% |
| Country | United States |
| Sector | health care |
Other stocks from the same country
- Regions Financial
- Reinsurance Group of America
- Reliance Steel & Aluminum
- Repligen
- Republic Services
- Regency Centers
Simple page computed from public prices (Yahoo Finance). Key figures are past facts; the AI's call is a forecast, not a certainty. Educational project, not investment advice.